Kalbitor available for hereditary angioedema (HAE)

Dyax Corporation announced the availability of Kalbitor (ecallantide for injection) for the treatment of acute attacks of hereditary angioedema in patients ≥16 years of age. Kalbitor is available for ordering as a 10mg/mL single-use vial through the Kalbitor Access program.

For more information call (888) 4KALBITOR or visit www.kalbitor.com.